Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review-Reference-Cited by-同舟云学术

Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

Published:2020-05-28 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Li Bin,Yan Cong,Zhu Jiamin,Chen Xiaobing,Fu Qihan,Zhang Hangyu,Tong Zhou,Liu Lulu,Zheng Yi,Zhao Peng,Jiang Weiqin,Fang Weijia

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference99 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

3. Hepatitis B virus-associated hepatocellular carcinoma;Xie;Adv Exp Med Biol,2017

4. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region;Zhu;Gut Liver,2016

5. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition;2024-09-08

2. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01

3. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models;Emerging Microbes & Infections;2024-08-08

4. Serum sPD‐1 and sPD‐L1 as predictive biomarkers for HBsAg clearance in HBeAg‐negative CHB patients undergoing IFN‐based therapy;Alimentary Pharmacology & Therapeutics;2024-06-25

5. The impact of PD-1 inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a retrospective study;Scientific Reports;2024-06-21